RGNX EPS Estimates
REGENXBIO Inc.
$8.12
-$0.35(-4.13%)
45
Overall
60
Value
30
Tech
47
Quality
Market Cap
$536.92M
Volume
370.26K
52W Range
$5.46 - $16.19
Target Price
$23.85
RGNX EPS estimates: the consensus estimate for REGENXBIO Inc.'s current fiscal year is -$3.26 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RGNX EPS Estimates
- EPS estimate, current quarter
- $-1.08
- EPS estimate, next quarter
- $-0.94
- EPS estimate, current year
- $-3.26
- EPS estimate, next year
- $-2.82
- EPS growth, 3-year
- +16.68%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.76 |
| 2024 | $-4.59 |
| 2023 | $-6.02 |
| 2022 | $-6.50 |
| 2021 | $3.01 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGNX | $8.12 | -4.1% | 370.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |